Cite
HARVARD Citation
Gonzalez-Bocco, I. et al. (n.d.). 1399. Clarithromycin–Rifampin-based Treatment for Non-tuberculous Mycobacterial Infections in Immunocompromised Patients Who Require Concomitant CYP-Metabolized Medications. Open forum infectious diseases. p. S784. [Online].